Groww Logo
Home>US Stocks>Assertio Therapeutics, Inc.

Assertio Therapeutics, Inc.

Healthcare
$2.69
- $0.17 (5.94%) 1D
1D
1W
1M
1Y
3Y
5Y

Performance

Today’s Low
$
    Today’s High
    $
    52W Low
    $
      52W High
      $
      Open PricePrev. CloseVolumeAvg. Volume
      $2.86$2.861,216,5351,107,621

      Fundamentals

      Market Cap$129.90M
      P/B Ratio1.2
      P/E Ratio40.1
      Enterprise Value$142.00M
      Div. Yield0.00%
      Book Value2.48
      EPS(TTM)0.20
      ROENA
      Understand Fundamentals

      About the Company

      Assertio Therapeutics, Inc. is an American pharmaceutical company and is a major supplier of products for the treatment of neurology, pain, and diseases of the central nervous system. The company was founded in the year 1995 and is listed on NASDAQ a
      Assertio Therapeutics, Inc. is an American pharmaceutical company and is a major supplier of products for the treatment of neurology, pain, and diseases of the central nervous system. The company was founded in the year 1995 and is listed on NASDAQ as ASRT. There are several products approved by the United States Food and Drug Administration, and the company even announced its name change from Depomed, Inc. to Assertio Therapeutics, Inc. The company is headquartered in Newark, California, as a joint venture between Elan and Depomed. The company is known to improve the bioavailability of generic drugs through the usage of polymers that are usually used in the food and cosmetics industry to reduce the side effects and lower the doses that are necessary. The company also has its diabetes treatment, Glumetza, approved for adults in the United States.
      ...Read more
      OrganisationAssertio Therapeutics, Inc.

      Company Financials

      *All values are in Million $
      No Graph Data To Display
      Quarterly
      Yearly
      See Details

      FAQs on Assertio Therapeutics, Inc.

      Can I Buy Assertio Therapeutics, Inc. Shares in India?

      Yes, Assertio Therapeutics, Inc. shares can be bought in India by opening an international trading account with Groww.

      How to Buy Assertio Therapeutics, Inc. Shares in India?

      One can easily invest in Assertio Therapeutics, Inc. shares from India by: Direct Investment - Opening an international trading account with Groww which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Assertio Therapeutics, Inc. shares. Indirect Investment - Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Assertio Therapeutics, Inc..

      What is the Share Price of Assertio Therapeutics, Inc.?

      The share price of Assertio Therapeutics, Inc. is in Dollars and if you are investing from India, you can always check the INR valuation before investing. The current Assertio Therapeutics, Inc. share price is $2.69 as of 16 May ‘22

      What is the Market Cap of Assertio Therapeutics, Inc.?

      The Assertio Therapeutics, Inc. market cap is $129.90M as of 16 May ‘22

      What is the PE and PB ratio of Assertio Therapeutics, Inc.?

      The PE and PB ratio of Assertio Therapeutics, Inc. is 40.1 and 1.2 as of 16 May ‘22
      ⓒ 2016-2022 Groww. All rights reserved, Built with in India
      MOST POPULAR ON GROWWVERSION - 2.3.7
      STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
      MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI

      ABOUT GROWW